Cargando…
Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
BACKGROUND: The visual system could be included in the diagnostic criteria for multiple sclerosis (MS) to demonstrate dissemination in space (DIS) and dissemination in time (DIT). OBJECTIVE: To investigate the diagnostic value of retinal asymmetry in MS. METHODS: A prospective, longitudinal study in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785044/ https://www.ncbi.nlm.nih.gov/pubmed/34764152 http://dx.doi.org/10.1136/jnnp-2021-327468 |
_version_ | 1784638877520101376 |
---|---|
author | Nij Bijvank, Jenny Uitdehaag, B M J Petzold, Axel |
author_facet | Nij Bijvank, Jenny Uitdehaag, B M J Petzold, Axel |
author_sort | Nij Bijvank, Jenny |
collection | PubMed |
description | BACKGROUND: The visual system could be included in the diagnostic criteria for multiple sclerosis (MS) to demonstrate dissemination in space (DIS) and dissemination in time (DIT). OBJECTIVE: To investigate the diagnostic value of retinal asymmetry in MS. METHODS: A prospective, longitudinal study in individuals with MS (n=151) and healthy controls (n=27). Optical coherence tomography (OCT) was performed at 0, 2 and 4 years. Macular ganglion cell and inner plexiform layer (mGCIPL) thickness was determined as well as measures for retinal asymmetry: the inter-eye percentage difference (IEPD) and inter-eye absolute difference (IEAD). Receiver operator characteristics curves were plotted and the area under the curve (AUC) was calculated for group comparisons of the mGCIPL, IEPD, IEAD and atrophy rates. RESULTS: The diagnostic accuracy of both the IEPD and IEAD for differentiating bilateral and unilateral MS optic neuritis was high and stable over time (AUCs 0.88–0.93). The IEPD slightly outperformed the IEAD. Atrophy rates showed low discriminatory abilities for differentiating MS from controls (AUC 0.49–0.58). CONCLUSION: The inter-eye differences of the mGCIPL have value for demonstration of DIS but in individuals with longstanding MS not for DIT. This may be considered as a test to detect DIS in future diagnostic criteria. Validation in a large prospective study in people presenting with symptoms suggestive of MS is required. |
format | Online Article Text |
id | pubmed-8785044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87850442022-02-04 Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics Nij Bijvank, Jenny Uitdehaag, B M J Petzold, Axel J Neurol Neurosurg Psychiatry Multiple Sclerosis BACKGROUND: The visual system could be included in the diagnostic criteria for multiple sclerosis (MS) to demonstrate dissemination in space (DIS) and dissemination in time (DIT). OBJECTIVE: To investigate the diagnostic value of retinal asymmetry in MS. METHODS: A prospective, longitudinal study in individuals with MS (n=151) and healthy controls (n=27). Optical coherence tomography (OCT) was performed at 0, 2 and 4 years. Macular ganglion cell and inner plexiform layer (mGCIPL) thickness was determined as well as measures for retinal asymmetry: the inter-eye percentage difference (IEPD) and inter-eye absolute difference (IEAD). Receiver operator characteristics curves were plotted and the area under the curve (AUC) was calculated for group comparisons of the mGCIPL, IEPD, IEAD and atrophy rates. RESULTS: The diagnostic accuracy of both the IEPD and IEAD for differentiating bilateral and unilateral MS optic neuritis was high and stable over time (AUCs 0.88–0.93). The IEPD slightly outperformed the IEAD. Atrophy rates showed low discriminatory abilities for differentiating MS from controls (AUC 0.49–0.58). CONCLUSION: The inter-eye differences of the mGCIPL have value for demonstration of DIS but in individuals with longstanding MS not for DIT. This may be considered as a test to detect DIS in future diagnostic criteria. Validation in a large prospective study in people presenting with symptoms suggestive of MS is required. BMJ Publishing Group 2022-02 2021-11-11 /pmc/articles/PMC8785044/ /pubmed/34764152 http://dx.doi.org/10.1136/jnnp-2021-327468 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Multiple Sclerosis Nij Bijvank, Jenny Uitdehaag, B M J Petzold, Axel Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics |
title | Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics |
title_full | Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics |
title_fullStr | Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics |
title_full_unstemmed | Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics |
title_short | Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics |
title_sort | retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics |
topic | Multiple Sclerosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785044/ https://www.ncbi.nlm.nih.gov/pubmed/34764152 http://dx.doi.org/10.1136/jnnp-2021-327468 |
work_keys_str_mv | AT nijbijvankjenny retinalintereyedifferenceandatrophyprogressioninmultiplesclerosisdiagnostics AT uitdehaagbmj retinalintereyedifferenceandatrophyprogressioninmultiplesclerosisdiagnostics AT petzoldaxel retinalintereyedifferenceandatrophyprogressioninmultiplesclerosisdiagnostics |